896139-85-8Relevant articles and documents
ErbB RECEPTOR INHIBITORS AS ANTI-TUMOR AGENTS
-
Page/Page column 170; 171, (2021/09/17)
Provided herein are novel compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.
Imidazo[1,2-a]pyridine compound, and preparation method and applications thereof
-
Paragraph 0067; 0069, (2017/08/28)
The invention discloses an imidazo[1,2-a]pyridine compound, and a preparation method and applications thereof. The imidazo[1,2-a]pyridine compound can inhibit the activity of NEK2 kinases as an NEK2 micro-molecular inhibitor with a novel structure. The in